HaploX
PrivateLast Round
Series D
Jul 25, 2022
Est. Valuation
$430M
Total Funding Raised
$86.22M
Company Overview
HaploX operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series D round in July 2022.
HaploX is a biotechnology company that provides genetic testing solutions, specializing in gene sequencing, liquid biopsies, and bioinformatics for cancer diagnostics and health screening.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HaploX Comparables
Compare HaploX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Geneplus Technology | 93% | |
| 求臻医学 | 89% | |
| Geneseeq | 87% |
For institutional investors. Book with your work email.
HaploX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 25, 2022 | ||||
| Series C | Jul 1, 2021 | ||||
| Series B Extension | Apr 1, 2020 | ||||
| Series B | Jun 28, 2018 | ||||
| Series A Extension | Dec 28, 2017 | ||||
Series A | May 16, 2016 |
For institutional investors. Book with your work email.
HaploX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Efung Capital | Series B |
| CNCB (Hong Kong) Investment Limited | Series D |
| SB China Capital | Series A Extension, Series D, Series A |
| Shenzhen Investment Holdings Co., Ltd. | Series B Extension |
| Mingjia Capital | Series C |
| Shenzhen Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2017
$32M round with SB China Capital
For institutional investors. Book with your work email.
HaploX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HaploX's valuation, stock price, and market status.
Is HaploX a public or private company?
HaploX is a private company.
What is the current stock price of HaploX?
HaploX is a private company, so its shares have no public market price. Caplight tracks HaploX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HaploX worth (valuation)?
HaploX's valuation is estimated at $430.0M based on funding round data.
Can I buy HaploX stock?
HaploX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HaploX's last funding round?
HaploX's most recent funding round was Series D on July 25, 2022.
Who are the main investors in HaploX?
Key investors in HaploX include Efung Capital, SB China Capital, Shenzhen Capital Group.
Will HaploX IPO soon?
No public IPO plans have been announced for HaploX.
How can I track HaploX secondary market activity?
Caplight tracks bids, offers, and trades in HaploX's shares on secondary markets.